Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia-Reference-Cited by-同舟云学术

Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Published:2015-12 Issue:1-3 Volume:169 Page:393-399
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Schreiner Andreas,Aadamsoo Kaire,Altamura A. Carlo,Franco Manuel,Gorwood Philip,Neznanov Nikolaj G.,Schronen Juan,Ucok Alp,Zink Mathias,Janik Adam,Cherubin Pierre,Lahaye Marjolein,Hargarter Ludger

Funder

Janssen-Cilag International NV

Janssen Pharmaceutica NV

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference30 articles.

1. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia;Alphs;Schizophr. Res.,2014

2. Rethinking the role of long-acting atypical antipsychotics in the community setting;Altamura;Int. Clin. Psychopharmacol.,2012

3. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease;Atkinson;Health Qual. Life Outcomes,2004

4. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study;Buckley;Schizophr. Bull.,2015

5. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia;Csernansky;N. Engl. J. Med.,2002

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence;ClinicoEconomics and Outcomes Research;2024-09

2. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis;Molecular Psychiatry;2024-08-22

3. Predictors of Readmission in Young Adults with First-Episode Psychosis: A Multicentric Retrospective Study with a 12-Month Follow-Up;Clinics and Practice;2024-06-24

4. Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults;Expert Review of Neurotherapeutics;2024-03-06

5. Current advances in pharmacotherapy for schizophrenia;Journal of the Korean Medical Association;2024-02-10